CLINICAL_TRIALS ClinicalTrials.gov record update

Assess Reactogenicity & Safety of a Booster of Either Tritanrix-HepB/Hib-MenAC or Tritanrix-HepB/Hiberix Given (Single-blind) at 15-18 (Philippines)/15-24 Mths (Thailand) & a Dose of Mencevax ACWY at 24-30 Mths (Open Label)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00228917
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:48.872313+00:00
Published At: 2017-03-29T00:00:00+00:00
Record Updated At: 2020-02-20
Results Posted At: 2017-03-29
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Whole Cell Pertussis", "Tetanus", "Hepatitis B", "Diphtheria", "Haemophilus Influenzae Type b", "Diphtheria-Tetanus-Pertussis-Hepatitis B-Haemophilus Influenzae Type b-Neisseria Meningitidis Vaccin"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2020-02-20"
protocolSection.identificationModule.nctId: "NCT00228917"
protocolSection.identificationModule.officialTitle: "Assess Reactogenicity \u0026 Safety of a Booster of Either Tritanrix-HepB/Hib-MenAC or Tritanrix-HepB/Hiberix Given (Single-blind) at 15-18 (Philippines)/15-24 Mths (Thailand) \u0026 a Dose of Mencevax ACWY at 24-30 Mths (Open Label)"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2017-03-29"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.